E
60 Degrees Pharmaceuticals, Inc. SXTP
$0.97 -$0.01-0.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income -0.72% -397.33% -1,294.74% -111.03% -130.84%
Total Depreciation and Amortization 5.62% -18.07% -39.10% -36.49% -27.57%
Total Amortization of Deferred Charges -- -- -- -- -100.00%
Total Other Non-Cash Items -63.22% 135.10% 181.98% 201.12% 195.49%
Change in Net Operating Assets -85.43% 108.38% 181.08% -52.48% 315.09%
Cash from Operations -66.80% -3.60% -15.83% -24.32% 10.38%
Capital Expenditure 62.41% 56.78% -84.90% -80.21% -8,766.67%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 193.82% 60.82% -8.64% -2,962.44% -1,590.95%
Cash from Investing 183.09% 58.32% -44.44% -1,529.94% -1,710.57%
Total Debt Issued -- -- -- -- -100.00%
Total Debt Repaid -- -- -- -- 100.00%
Issuance of Common Stock -14.97% -27.76% -27.66% -7.03% -7.03%
Repurchase of Common Stock 20.81% 20.81% 20.81% 32.78% 18.83%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -32.11% -23.19% 480.11% -- 168.68%
Cash from Financing -15.21% -13.02% -16.45% 8.94% 10.09%
Foreign Exchange rate Adjustments -88.54% -88.94% -113.80% -99.19% 115.59%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -24.68% -74.94% -80.56% -125.73% -39.18%